Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication

nork Ueno, Takayuki, Saji, Shigehira, Masuda, Norikazu, Iwata, Hiroji, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Sasano, Hironobu, Toi, Masakazu
Argitaratua izan da ESMO Open (2019)

Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial

nork Ueno, Takayuki, Saji, Shigehira, Masuda, Norikazu, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Iwata, Hiroji, Yamanaka, Takeharu, Sasano, Hironobu, Toi, Masakazu
Argitaratua izan da ESMO Open (2018)

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy

nork Ueno, Takayuki, Saji, Shigehira, Sugimoto, Masahiro, Masuda, Norikazu, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Iwata, Hiroji, Imoto, Shigeru, Sasano, Hironobu, Toi, Masakazu
Argitaratua izan da BMC Cancer (2016)